Form 4 for DRIO DarioHealth Corp.
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-15 · accession 0001104659-25-049388 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-15 | 2025-05-15 | DRIO | Franco-Yehuda Chen | CFO | A - Grant | $0.00 | +500.0K | 500.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | A | A | 500,000 | $0.00 | 500,000 | D | — | — | (F1) The restricted shares vest over three years, with one third of such shares vesting on April 27, 2026, and the remaining shares vesting in equal quarterly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date The vesting period shall immediately end, and all shares shall immediately vest, in the event of a change in control of the Registrant (as defined in the Registrant's 2020 Equity incentive Plan, as amended). |